Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 29,653 $ 13,148
Short term cash deposits 30,151
Restricted deposit 23 13
Trade receivables 9 270
Other accounts receivable and prepaid expenses 543 424
Inventories 1,430 1,081
Total current assets 31,658 45,087
Non-current assets:    
Restricted deposit 188 213
Operating lease right-of-use assets 2,711 2,953
Property and equipment, net 2,966 2,728
Intangible assets, net 245 243
Total non-current assets 6,110 6,137
Total assets 37,768 51,224
Current liabilities:    
Trade payables 1,133 1,034
Operating lease liabilities 529 519
Deferred revenues 32
Accrued liabilities and other 1,443 1,429
Total current liabilities 3,105 3,014
Non-current liabilities:    
Operating lease liabilities 2,382 3,089
Total non-current liabilities 2,382 3,089
Total liabilities 5,487 6,103
Commitments and contingencies  
Shareholders’ Equity:    
Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of December 31, 2022 and December 31, 2021; issued and outstanding: 11,186,481 and 10,772,024 ordinary shares as of December 31, 2022 and December 31, 2021, respectively 4,873 4,664
Additional paid in capital 118,099 114,223
Currency translation differences (969) (969)
Accumulated deficit (89,722) (72,797)
Total shareholders’ equity 32,281 45,121
Total liabilities and shareholders’ equity $ 37,768 $ 51,224